EP1807123A4 - A method for improvement of tolerance for therapeutically effective agents delivered by inhalation - Google Patents

A method for improvement of tolerance for therapeutically effective agents delivered by inhalation

Info

Publication number
EP1807123A4
EP1807123A4 EP05790821A EP05790821A EP1807123A4 EP 1807123 A4 EP1807123 A4 EP 1807123A4 EP 05790821 A EP05790821 A EP 05790821A EP 05790821 A EP05790821 A EP 05790821A EP 1807123 A4 EP1807123 A4 EP 1807123A4
Authority
EP
European Patent Office
Prior art keywords
inhalation
tolerance
improvement
therapeutically effective
effective agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05790821A
Other languages
German (de)
French (fr)
Other versions
EP1807123A2 (en
Inventor
William R Baker
Thomas Hofmann
Alan Bruce Montgomery
Kevin Stapleton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Sciences Inc
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2004/036926 external-priority patent/WO2005044233A1/en
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of EP1807123A2 publication Critical patent/EP1807123A2/en
Publication of EP1807123A4 publication Critical patent/EP1807123A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
EP05790821A 2004-09-20 2005-01-28 A method for improvement of tolerance for therapeutically effective agents delivered by inhalation Withdrawn EP1807123A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61165604P 2004-09-20 2004-09-20
PCT/US2004/036926 WO2005044233A1 (en) 2003-11-04 2004-11-04 Formulations of n-oxide prodrugs of local anesthetics for the treatment of pulmonary inflammation associated with asthma, brochitis, and copd
US63502204P 2004-12-09 2004-12-09
PCT/US2005/003532 WO2006060027A2 (en) 2004-09-20 2005-01-28 A method for improvement of tolerance for therapeutically effective agents delivered by inhalation

Publications (2)

Publication Number Publication Date
EP1807123A2 EP1807123A2 (en) 2007-07-18
EP1807123A4 true EP1807123A4 (en) 2010-01-13

Family

ID=36565461

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05790821A Withdrawn EP1807123A4 (en) 2004-09-20 2005-01-28 A method for improvement of tolerance for therapeutically effective agents delivered by inhalation

Country Status (4)

Country Link
EP (1) EP1807123A4 (en)
AU (1) AU2005310312A1 (en)
CA (1) CA2581053A1 (en)
WO (1) WO2006060027A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10617703B2 (en) 2014-12-10 2020-04-14 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11690815B2 (en) 2015-08-05 2023-07-04 Cmpd Licensing Llc Hyperkeratotic skin condition treatments and compositions
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US10898455B2 (en) 2016-01-07 2021-01-26 Cmpd Licensing, Llc Urea cream formulations
US11278590B2 (en) 2015-08-05 2022-03-22 Cmpd Licensing, Llc Compositions and methods for treating nail infections
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US10898491B2 (en) 2015-12-18 2021-01-26 Cmpd Licensing, Llc Compositions and methods for treating an infection
CA3004492A1 (en) * 2015-11-18 2017-05-26 Glaxosmithkline Intellectual Property (No.2) Limited Pharmaceutical compositions of ribavirin
CN105920020B (en) * 2016-06-23 2019-01-08 潘海英 A kind of pharmaceutical composition and its preparation method and application for treating pulmonary disease
US9999604B2 (en) 2016-11-17 2018-06-19 Cmpd Licensing, Llc Compounded solutions of diclofenac and lidocaine and methods
US11737975B2 (en) 2016-11-17 2023-08-29 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
US10525025B2 (en) 2016-11-17 2020-01-07 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
US10966946B2 (en) 2016-11-17 2021-04-06 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
WO2018204393A1 (en) 2017-05-02 2018-11-08 Neuronasal, Llc Use of n-acetylcysteine to treat central nervous system disorders

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037896A1 (en) * 1997-02-26 1998-09-03 Mayo Foundation For Medical Education And Research Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics
US20030171402A1 (en) * 2000-06-23 2003-09-11 Gleich Gerald J. Method of treating neutrophil-related diseases with topical anesthetics

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037896A1 (en) * 1997-02-26 1998-09-03 Mayo Foundation For Medical Education And Research Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics
US20030171402A1 (en) * 2000-06-23 2003-09-11 Gleich Gerald J. Method of treating neutrophil-related diseases with topical anesthetics

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DECCO M L ET AL: "Nebulized lidocaine in the treatment of severe asthma in children: a pilot study", ANNALS OF ALLERGY, ASTHMA & IMMUNOLOGY, ARLINGTON HEIGHTS, IL, US, vol. 82, no. 1, 1 January 1999 (1999-01-01), pages 29 - 32, XP009126326, ISSN: 1081-1206 *
HUNT L W ET AL: "EFFECT OF NEBULIZED LIDOCAINE ON SEVERE GLUCOCORTICOID-DEPENDENT ASTHMA", MAYO CLINIC PROCEEDINGS, MAYO MEDICAL VENTURES, ROCHESTER, MN, vol. 71, no. 4, 1 April 1996 (1996-04-01), pages 361 - 368, XP002069072, ISSN: 0025-6196 *
IACONO A T ET AL: "DOSE-RELATED REVERSAL OF ACTUE LUNG REJECTION BY AEROSOLIZED CYCLOSPORINE", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMERICAN LUNG ASSOCIATION, NEW YORK, NY, US, vol. 155, no. 5, 1 May 1997 (1997-05-01), pages 1690 - 1698, XP000939164, ISSN: 1073-449X *
PARI AEROSOL RESEARCH INSTITUTE: "PARI's eFlow(R), an Electronic Aerosol Device for Medication Delivery, Receives FDA 510(k) Market Clearance", 18 May 2004 (2004-05-18), Monterey, California, USA, pages 1 - 2, XP002558312, Retrieved from the Internet <URL:http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/05-18-2004/0002176356&EDATE> [retrieved on 20091201] *

Also Published As

Publication number Publication date
AU2005310312A1 (en) 2006-06-08
WO2006060027A2 (en) 2006-06-08
WO2006060027A3 (en) 2007-12-13
CA2581053A1 (en) 2006-06-08
EP1807123A2 (en) 2007-07-18

Similar Documents

Publication Publication Date Title
EP1807123A4 (en) A method for improvement of tolerance for therapeutically effective agents delivered by inhalation
IL181531A0 (en) A kit for delivering drugs by nebulization
HK1200694A1 (en) Liposomes useful for drug delivery
GB2412594B (en) Improvements relating to respiratory masks
AU301937S (en) Elbow for mask
GB0515592D0 (en) Nozzle for a nasal inhaler
EP1986699A4 (en) Rna interference agents for therapeutic use
IL203766A0 (en) Apparatus for intracellular delivery of a therapeutic agent
ZA200703557B (en) Method for treatment of a gas
PL1817282T3 (en) Phenoxyacetic acid derivatives useful for treating respiratory diseases
EP1755638A4 (en) Multiple agent therapy for sexual dysfunction
EP1750677A4 (en) Oral therapeutic compound delivery system
ZA200704386B (en) Method for increasing a ethaboxam effectiveness
EP1806148A4 (en) Medicinal composition for inhalation
GB2416793B (en) Method for completing a well
EP2053961A4 (en) Method for distribution of a drug
EP1846432A4 (en) Method for making targeted therapeutic agents
HK1107786A1 (en) Blister for inhalers
EG26650A (en) Method of operating a shiplift
IL177703A0 (en) Method of evaluating the therapeutic potential of a vaccine for mucosal administration
EP1731171A4 (en) Preventive/remedy for respiratory diseases
GB0600168D0 (en) A therapeutic composition
EP1843780A4 (en) A method of treatment
AU302568S (en) Elbow for mask
GB0607153D0 (en) Therapeutic Method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070327

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR LV MK YU

RIN1 Information on inventor provided before grant (corrected)

Inventor name: STAPLETON, KEVIN

Inventor name: MONTGOMERY, ALAN, BRUCE

Inventor name: HOFMANN, THOMAS

Inventor name: BAKER, WILLIAM, R.

DAX Request for extension of the european patent (deleted)
R17D Deferred search report published (corrected)

Effective date: 20071213

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GILEAD SCIENCES, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20091216

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/47 20060101ALI20091208BHEP

Ipc: A61K 31/24 20060101ALI20091208BHEP

Ipc: A61K 9/14 20060101ALI20091208BHEP

Ipc: A61K 9/12 20060101AFI20091208BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120801